- $5.3 BnWorld market, 2023
- $7.8 BnProjected, 2033
- 4%Growth a year (CAGR)
- 54Active clinical trials worldwide
Largest countries
Market size in 2023 · growth a year to 2033
-
1
US
$2.2 Bn
2% a year · 42% of the world -
2
China
$426 Mn
5.5% a year · 8% of the world -
3
Canada
$424 Mn
4% a year · 8% of the world -
4
Japan
$329 Mn
4.5% a year · 6.2% of the world -
5
Germany
$194 Mn
2.2% a year · 3.7% of the world -
6
France
$146 Mn
3% a year · 2.7% of the world -
7
UK
$138 Mn
2% a year · 2.6% of the world -
8
Brazil
$133 Mn
5% a year · 2.5% of the world -
9
Italy
$127 Mn
3.5% a year · 2.4% of the world -
10
Ecuador
$106 Mn
4.6% a year · 2% of the world
Most clinical trials
Active trials by country (ClinicalTrials.gov)
See every trial on ClinicalTrials.gov (opens in a new tab)
Australia
Hong Kong
ThailandOver The Counter (OTC) Sleep Aid Products by country and region
Spain
India
Saudi Arabia
Mexico
South Africa
UAE
Egypt
Philippines
Malaysia
Singapore
Kenya
New Zealand
Russia"–" means we have no size for that place yet. 2033 values are projected from the 2023 size and the CAGR. Regions count only the countries we report on for trials.
Latest research 2,800 papers since 2021
- US real-world data: sleep and mental health burden in chronic spontaneous urticaria. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2026
- Intervention with Exogenous Melatonin Has No Adverse Effects on Cardiometabolic Parameters of Overweight Night Workers without Cardiometabolic Abnormalities. Sleep science (Sao Paulo, Brazil), 2026
- Rapid Eye Movement Sleep Behavior Disorder as a Prodromal Manifestation of Alpha-Synucleinopathies. Cureus, 2026
- Melatonin in pediatric populations: promise or peril? Current opinion in pulmonary medicine, 2026
- Overwork and structural alterations in serotonin-melatonin-related brain systems in healthcare workers. Occupational and environmental medicine, 2026
Compare Over The Counter (OTC) Sleep Aid Products side by side
Key companies in Over The Counter (OTC) Sleep Aid Products
AstraZeneca PLC
Biodem
Cadwell Industries, Inc
Fisher & Paykel Healthcare Limited
GSK PLC
Koninklijke Philips NV.
Merck & Co Inc
Novartis Ag
Pfizer , Inc
Sanofi S.A
SleepMed Inc
Quick answers
How big is the Over The Counter (OTC) Sleep Aid Products market?
The world Over The Counter (OTC) Sleep Aid Products market was worth about $5.3 Bn in 2023 and is projected to reach $7.8 Bn by 2033, growing 4% a year (CAGR).
Which country has the largest Over The Counter (OTC) Sleep Aid Products market?
The US is the largest of the 24 countries we cover, at $2.2 Bn in 2023. India grows fastest, at 7% a year.
How many clinical trials are running in Over The Counter (OTC) Sleep Aid Products?
ClinicalTrials.gov lists 54 active trials worldwide (recruiting, about to start or running), most of them in the US, as of 10 Nov 2026.
How much research is published on Over The Counter (OTC) Sleep Aid Products?
PubMed lists about 2,800 papers on the topic since 2021.
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov. Research: PubMed (US National Library of Medicine). Fetched 10 Nov 2026. Trials and papers are found by search words, so counts are a guide.